FGFR2 and gastric cancer: We unveiled for the first time a link between ESRP1 amplification and FGFR2-IIIc high expression, through the axis ESRP1amp-FGFR2norm-FGFR2-IIIchigh, which seems to particularly determine the poor overall survival of patients with diffuse-type GC.